ACSBG1: Acyl-CoA Synthetase Bubblegum Family Member 1

Key enzyme in very long-chain fatty acid metabolism and peroxisomal function

Gene Information Card

Symbol ACSBG1
Full Name Acyl-CoA Synthetase Bubblegum Family Member 1
Gene Type Protein coding
Chromosomal Location 15q24.1
NCBI Gene ID 23205 ncbi.nlm.nih.gov/gene/23205
Ensembl ID ENSG00000137807
UniProt ID Q96GR2
OMIM ID 614362
HGNC ID 24013
Aliases BG1, BGM, BG, FLJ10156, MGC131971

Description

ACSBG1 encodes a member of the acyl-CoA synthetase family that activates very long-chain fatty acids (VLCFAs) by converting them to acyl-CoAs. This enzyme is critical for VLCFA degradation in peroxisomes and for incorporation into complex lipids. Mutations in ACSBG1 are associated with X-linked adrenoleukodystrophy (ALD)-like phenotypes and other peroxisomal disorders. The protein is highly expressed in brain, adrenal glands, and testis.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
X-linked adrenoleukodystrophy (ALD) Impaired VLCFA activation leads to accumulation of VLCFAs in tissues, causing demyelination and adrenal insufficiency. ClinVar, OMIM
Peroxisomal acyl-CoA oxidase deficiency Deficient ACSBG1 activity reduces peroxisomal beta-oxidation of VLCFAs. OMIM
Hereditary spastic paraplegia (HSP) VLCFA accumulation due to ACSBG1 mutations may contribute to axonal degeneration. NCBI Gene, ClinVar

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.5 Medium
Adrenal gland 18.3 High
Testis 15.1 High
Liver 6.2 Low
Kidney 4.8 Low
Cell Line Expression
Cell Line nTPM Notes
SH-SY5Y (neuroblastoma) 14.2 Neuronal model
HepG2 (hepatocellular carcinoma) 5.1 Hepatic expression
HeLa (cervical carcinoma) 3.8 Low expression
A549 (lung carcinoma) 2.9 Low expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1520C>T (p.Pro507Leu) Missense 0.001% Reduced enzyme activity; associated with ALD-like phenotype
c.214G>A (p.Gly72Arg) Missense 0.0005% Loss of function; impaired VLCFA activation
c.1018_1020del (p.Leu340del) In-frame deletion 0.0002% Altered substrate binding; dominant negative effect
Mutation functional classification

Loss of Function (LOF)

Missense mutations (e.g., p.Gly72Arg) reduce or abolish acyl-CoA synthetase activity, leading to VLCFA accumulation.

Gain of Function (GOF)

No gain-of-function mutations reported in ACSBG1.

Dominant Negative (DN)

In-frame deletion p.Leu340del may interfere with dimerization, reducing wild-type enzyme function.

Gene Ontology (GO)

• GO:0003987 - acetate-CoA ligase activity • GO:0006631 - fatty acid metabolic process
• GO:0005777 - peroxisome • GO:0016874 - ligase activity
• GO:0033540 - very long-chain fatty acid metabolic process

Pathways

Peroxisomal beta-oxidation of VLCFAs (Reactome: R-HSA-77289)
Fatty acid activation (KEGG: hsa00071)

Protein Summary

ACSBG1 is a 689-amino acid peroxisomal membrane protein that catalyzes the ATP-dependent conversion of very long-chain fatty acids (C22:0, C24:0, C26:0) to their acyl-CoA derivatives. This activation is essential for subsequent beta-oxidation in peroxisomes. The protein contains an AMP-binding domain and a fatty acyl-CoA synthetase signature motif. Defects in ACSBG1 disrupt VLCFA homeostasis, leading to neurological and adrenal pathologies.

Related Products

Product name Cat.No. Species Gene ID
ACSBG1 Knockout HEK293 Cell Line EDJ-KQ7883 Human 23205 Details Get a Quote
ACSBG1 Knockout HCT 116 Cell Line EDJ-KQ33474 Human 23205 Details Get a Quote
ACSBG1 Knockout HeLa Cell Line EDJ-KQ55704 Human 23205 Details Get a Quote
ACSBG1 Knockout A-549 Cell Line EDJ-KQ64201 Human 23205 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: